Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.
暂无分享,去创建一个
R. Langer | J. Slotta-Huspenina | M. Neurath | A. Meining | F. Greten | V. Becker | K. Rudolph | A. Lechel | D. Horst | T. Kirchner | Paul K. Ziegler | Olivia Prazeres da Costa | S. Schwitalla | F. Bader | K. Rudolph | Y. begus-Nahrmann | I. Kerle | Paul K Ziegler | Olivia Prazeres da Costa | Yvonne begus-Nahrmann
[1] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[2] Stefan Wirtz,et al. Confocal laser endomicroscopy and narrow-band imaging-aided endoscopy for in vivo imaging of colitis and colon cancer in mice , 2011, Nature Protocols.
[3] J. M. Mullin,et al. Epithelial Tight Junctional Changes in Colorectal Cancer Tissues , 2011, TheScientificWorldJournal.
[4] Steffen Jung,et al. CKIα ablation highlights a critical role for p53 in invasiveness control , 2011, Nature.
[5] J. Imura,et al. GROα promotes invasion of colorectal cancer cells. , 2010, Oncology reports.
[6] F. Greten,et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. , 2010, Cancer cell.
[7] D. Artis,et al. Intestinal bacteria and the regulation of immune cell homeostasis. , 2010, Annual review of immunology.
[8] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[9] Umar Mahmood,et al. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.
[10] F. Greten,et al. IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasis , 2009, EMBO reports.
[11] J. Budczies,et al. Invasion associated up‐regulation of nuclear factor κB target genes in colorectal cancer , 2009, Cancer.
[12] D. Meek. Tumour suppression by p53: a role for the DNA damage response? , 2009, Nature Reviews Cancer.
[13] A. Levine,et al. The first 30 years of p53: growing ever more complex , 2009, Nature Reviews Cancer.
[14] Jian Yu,et al. PUMA suppresses intestinal tumorigenesis in mice. , 2009, Cancer research.
[15] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[16] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[17] Ozge Canli,et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. , 2009, Cancer cell.
[18] C. Prinz,et al. Detection of cholangiocarcinoma in vivo using miniprobe-based confocal fluorescence microscopy. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[19] M. Vieth,et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett’s oesophagus , 2008, Gut.
[20] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[21] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[22] Nobuyuki Tanaka,et al. p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.
[23] Eduardo Sontag,et al. Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.
[24] E. Bandrés,et al. TWIST1 Overexpression is Associated with Nodal Invasion and Male Sex in Primary Colorectal Cancer , 2008, Annals of Surgical Oncology.
[25] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[26] M. Neurath,et al. High resolution colonoscopy in live mice , 2006, Nature Protocols.
[27] G. Evan,et al. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression , 2006, Nature.
[28] T. Nagayasu,et al. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors , 2005, Journal of Clinical Pathology.
[29] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[30] Daniel Metzger,et al. Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.
[31] M. Karin,et al. IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Benjamin,et al. Angiogenesis: Tumorigenesis and the angiogenic switch , 2003, Nature Reviews Cancer.
[33] William C Hahn,et al. Rules for making human tumor cells. , 2002, The New England journal of medicine.
[34] D. Gumucio,et al. cis Elements of the Villin Gene Control Expression in Restricted Domains of the Vertical (Crypt) and Horizontal (Duodenum, Cecum) Axes of the Intestine* , 2002, The Journal of Biological Chemistry.
[35] S. Chae,et al. Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas. , 2002, Journal of Korean medical science.
[36] A. Berns,et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.
[37] H. Clevers,et al. APC, Signal transduction and genetic instability in colorectal cancer , 2001, Nature Reviews Cancer.
[38] L. Donehower,et al. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Miller,et al. Increased tight junctional permeability is associated with the development of colon cancer. , 1999, Carcinogenesis.
[40] N. Perkins,et al. Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.
[41] D. Winton,et al. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Lander,et al. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] Clarke Ar,et al. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. , 1995 .
[44] M. Cummings,et al. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. , 1995, Oncogene.
[45] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[46] E. E. Gresch. Genetic Alterations During Colorectal-Tumor Development , 1989 .